Johnson Matthey Beats Fraud Claim Over £325M Pharma Deal

By Eddie Beaver ( May 1, 2026, 3:37 PM BST) -- Johnson Matthey defeated on Friday a claim that it acted fraudulently in the £325 million ($444 million) sale of one of its pharmaceutical businesses, despite a finding by a London court that the chemicals business had failed to disclose to the buyer significant details about the transaction....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login